Press releasePRNewswire
Xtant Medical Holdings
XTNT · NYSE American
$0.303+$0.012 (+4.12%)TodayMarket closed ·
Prev close $0.291
Latest news
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate
- Press releasePRNewswire
Xtant Medical Reports Second Quarter 2026 Financial Results
- Press releasePRNewswire
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
- Press releasePRNewswire
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
- News
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
- News
Earnings Scheduled For May 13, 2026
- Press releasePRNewswire
Xtant Medical Reports First Quarter 2026 Financial Results
- Press releasePRNewswire
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
- Press releasePRNewswire
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
- Press releasePRNewswire
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
- News
Earnings Scheduled For March 31, 2026
- Press releasePRNewswire
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
- Press releasePRNewswire
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releasePRNewswire
Xtant Medical Finalizes Companion Spine Transactions
- Press releasePRNewswire
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
- Press releasePRNewswire
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
- Press releaseBusiness Wire
Companion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex® and CoFix® Spine Implants and All Other Implant Systems, from Xtant™ Medical Holdings, Inc.
- Press releasePRNewswire
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
- News
Xtant Medical Hldgs Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $33.300M Beat $32.700M Estimate
- Press releasePRNewswire
Xtant Medical Reports Third Quarter 2025 Financial Results
- News
Earnings Preview For Xtant Medical Hldgs
- Press releasePRNewswire
Xtant Medical Announces Commercial Launch of CollagenX™
- Press releasePRNewswire
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
- Press releasePRNewswire
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
- Press releasePRNewswire
Xtant Medical Reports Second Quarter 2025 Financial Results
- News
Earnings Preview For Xtant Medical Hldgs
- Press releasePRNewswire
Xtant Medical to Attend the CG 45th Annual Growth Conference
- Press releasePRNewswire
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
- Press releaseBusiness Wire
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant™ Medical Holdings, Inc.
- News
Xtant Medical Holdings, Announces The Company Has Entered Into Agreements To Sell Certain Coflex And Cofix Interlaminar Stabilization Implant Assets And All OUS Entities Of Paradigm Spine GmbH To Companion Spine LLC. Proceeds Of Transaction Total $19.2M
- Press releasePRNewswire
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine
- Press releasePRNewswire
Xtant Medical Announces the Launch of OsteoFactor Pro™
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.